Overview

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Status:
Available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical protocol is to treat individuals with Tecovirimat after exposure to orthopox viruses.
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command
U.S. Army Medical Research and Materiel Command